Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/544319 stock hub

BOM/544319 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/544319is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

44.5B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/544319

In the news

Latest news · BOM/544319

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.8

P25 n/aP50 n/aP75 n/a

Trailing P/E43.8

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC11.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/544319 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

141

Groups with data

Currency

INR

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	194
Employees Change	81%
Employees Change Percent	71.68
Enterprise value	INR 45.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 44.5B
Price	INR 967
Price currency	INR
Rev Per Employee	28,528,865.98x
Sic	2834
Symbol	bom/544319
Website	https://senorespharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.28%
EV Earnings	44.35x
EV/EBIT	34.67x
EV/EBITDA	29.72x
EV/Sales	8.14x
Forward P/E	33.77x
P/B ratio	5.33x
P/E ratio	43.77x
P/S ratio	8.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.48%
EBITDA Margin	27.13%
Gross margin	54.9%
Gross Profit	INR 3B
Gross Profit Growth	41.24%
Gross Profit Growth Q	57%
Net Income	INR 1B
Net Income Growth	79.28%
Net Income Growth Q	84.28%
Pretax Margin	23.92%
Profit Margin	18.36%
Profit Per Employee	INR 5.2M
ROIC	11.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	95.77%
EPS Growth	40.32
EPS Growth Q	44.64
Revenue Growth	43.2x
Revenue Growth Q	60.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2B
Debt	INR 2.4B
Debt EBITDA	INR 1.59
Debt Equity	INR 0.29
Equity	INR 8.3B
Interest Coverage	6.28
Net Cash	INR -385.3M
Net Cash By Market Cap	INR -0.87
Net Debt EBITDA	INR 0.26
Net Debt Equity	INR 0.05
Tangible Book Value	INR 5.2B
Tangible Book Value Per Share	INR 105

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	95.68%
200-day SMA	767.4
50-day SMA	812.7
50-day SMA vs 200-day SMA	50over200
All Time High	975
All Time High Change	-0.87%
All Time High Date	2026-05-08
All Time Low	440
All Time Low Change	119.67%
All Time Low Date	2025-01-13
ATR	34.79
Ch YTD	17.63
High	975
High52	975
High52 Date	2026-05-08
High52ch	-0.87%
Low	931.3
Low52	474
Low52 Date	2025-05-09
Low52ch	103.91%
Ma50ch	18.93%
Price vs 200-day SMA	25.95%
RSI	69.96
RSI Monthly	76.86
RSI Weekly	69.56
Sharpe ratio	1.75x
Sortino ratio	3.21
Total Return	-27.75%
Tr YTD	17.63
Tr1m	25.33%
Tr1w	8.28%
Tr3m	17.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.3B
Operating Income Growth	67.97
Operating Income Growth Q	114.8
Operating margin	23.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,451,748%
Shares Insiders	36.28%
Shares Institutions	11.75%
Shares Qo Q	-12.28%
Shares Yo Y	27.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	15,121.1x
Bv Per Share	164.4
Ch1m	25.33
Ch1w	8.28
Ch1y	95.68
Ch3m	17.17
Ch6m	17.54
Change	3.66%
Change From Open	2.28
Close	932.5
Days Gap	1.35
Depreciation Amortization	202,050,000
Dollar Volume	22,307,007.5
Earnings Date	2026-05-14
EBIT	INR 1.3B
EBITDA	INR 1.5B
EPS	INR 22.43
F Score	1
Fiscal Year End	March
Founded	2,017
Graham Number	300.19288
Graham Upside	-68.94
Income Tax	INR 295.5M
Is Primary Listing	0
Last Earnings Date	2026-01-20
Last Report Date	2025-12-31
Ma150	794.9
Ma150ch	21.6%
Ma20	891.6
Ma20ch	8.4%
Next Earnings Date	2026-05-14
Open	945
Position In Range	80.69
Price Date	2026-05-08
Price EBITDA	INR 29.61
Ptbv Ratio	8.57
Relative Volume	1.53x
Revenue	5,534,600,000x
Tax By Revenue	5.34x
Tax Rate	22.32%
Tr6m	17.54%
Volume	23,079

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/544319 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/544319 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/544319?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.8%

Share of float held by funds and institutions

Insider ownership

+36.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+27.7%

Negative means the company is buying back shares.

Technical

BOM/544319 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.0

Neutral momentum band

Price vs 200-day MA

+25.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/544319

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/544319 stock rating?

bom/544319 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/544319 analysis?

The full report lives at /stocks/bom/544319/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/544319?

The latest report frames bom/544319 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/544319 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.